Regulation

Is Reform the Key to a Fairer and Freer Healthcare Market?
Public Policy Is Reform the Key to a Fairer and Freer Healthcare Market?

The healthcare system in the United States is a complex and often contentious topic. Recent events have brought to light the frustrations many people feel toward health insurance companies, particularly regarding the denial of healthcare claims. However, rather than resorting to violence or

Addressing Mental Health Challenges in the Digital Workplace Era
Technology Addressing Mental Health Challenges in the Digital Workplace Era

The rapid digitalization of the workplace has undeniably transformed the way we work, introducing tools and technologies that improve efficiency and flexibility. However, this digital transformation has also brought about significant changes that deeply impact our mental health. At a recent

DEA Proposes Telehealth Registration for Controlled Substance Prescribing
Technology DEA Proposes Telehealth Registration for Controlled Substance Prescribing

The U.S. Drug Enforcement Agency (DEA) has announced a significant initiative to create a special telehealth registration framework for prescribers of medically necessary controlled substances. This new framework will allow qualified practitioners to prescribe these substances without requiring an

Can Big Data and AI Transform the U.S. Healthcare System?
Public Policy Can Big Data and AI Transform the U.S. Healthcare System?

The recent Supreme Court decision overruling Chevron deference has created a significant impact across numerous industries, including healthcare. This ruling has stripped some of the latitude and autonomy that federal agencies previously had to define, interpret, and enforce regulations. As a

Can Cellectar's Radiotherapeutics Revolutionize Cancer Treatment by 2025?
Care Can Cellectar's Radiotherapeutics Revolutionize Cancer Treatment by 2025?

Cellectar Biosciences has recently unveiled its strategic initiatives for 2025, showcasing their ambitious plans at the Biotech Showcase during the JP Morgan Healthcare Conference, aiming to transform cancer treatment. The company is focused on advancing its lead radiotherapeutic agent, iopofosine

Senate Report Highlights Deteriorating Care in Private Equity-Owned Hospitals
Care Senate Report Highlights Deteriorating Care in Private Equity-Owned Hospitals

A recent investigation led by the U.S. Senate Committee on the Budget has raised alarm over the deteriorating care in hospitals owned by private equity (PE) firms across the United States. This bipartisan probe, spearheaded by Senators Chuck Grassley and Sheldon Whitehouse, delved into the growing

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later